D. E. SHAW & CO, L.P.
Follow13F filer, CIK 1009268, New York, NY
D. E. SHAW & CO, L.P. filed a 13F-NT notice for the quarter ended 2026-06-30 on 2026-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-NT 0001104659-26-097221
This filer reports no holdings of its own for Q2 2026. It filed a 13F-NT notice, and its holdings are in the report of . How notices are handled.
Changes against Q1 2026 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.
Part of the filer group D. E. Shaw & Co., Inc.
D. E. Shaw Adviser II, L.L.C.D. E. Shaw & Co., Inc.
- D. E. Shaw Adviser II, L.L.C.
- D. E. Shaw & Co., Inc.
- D. E. Shaw Composite Adviser, L.L.C.
- D. E. Shaw Heliant Adviser, L.L.C.
- D. E. Shaw Investment Management, L.L.C.
- D. E. Shaw Multi-Asset Adviser, L.L.C.
- David E. Shaw
- D. E. Shaw & Co., L.L.C.
- D. E. Shaw Valence Portfolios, L.L.C.
Stakes and trades reported after 2026-06-30
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- GOSS GOSSAMER BIO INC: 13D/A 369,459 shares, 6% of the class, 13D/A filed 2026-10-08, 0001104659-26-114792Timeline
Accepted , ingested
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-NT 0001104659-26-097221 | notice | 2026-08-14 | acceptance time not in the bulk data set |